Mental health infrastructure, antipsychotic prescribing patterns, and reimbursement systems vary significantly across regions, shaping the tardive dyskinesia market in distinct ways. Understanding these dynamics helps pharmaceutical companies and healthcare providers plan effective strategies.
North America leads the tardive dyskinesia market, supported by high awareness, advanced mental health...